Helicobacter pylori seropositivity and coronary heart disease incidence

Circulation

Volumn 98, Issue 9, 1998, Pages 845-850

  Folsom, Aaron R ^a   Nieto, F Javier ^b   Sorlie, Paul ^c   Chambless, Lloyd E ^d   Graham, David Y ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Coronary disease; Epidemiology; Helicobacter pylori

Indexed keywords

BACTERIUM ANTIBODY; FIBRINOGEN; HOMOCYSTEINE; IMMUNOGLOBULIN G; PYRIDOXAL 5 PHOSPHATE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CORONARY RISK; CYTOMEGALOVIRUS; EDUCATION; FEMALE; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS 1; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEROLOGY;

EID: 0344269334     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.9.845     Document Type: Article

References (47)

1. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437-439.
2. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet. 1997;350:430-436.
3. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995;311: 711-714.
4. Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield TC, Mendall MA. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet. 1994;343:1634-1635.
5. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C Reactive protein and its relation to cardiovascular risk factors: a population-based cross-sectional study. BMJ. 1996;312:1061-1065.
6. Sung JJY, Sanderson JE. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart. 1996;76:305-307.
7. Miragliotta G, Del Prete R, Mosca A. Helicobacter pylori infection and coronary heart disease. Lancet. 1994;344:751. Comment.
8. Blasi F, Ranzi ML, Erba M, Tarsia P, Raccanelli R, Fagetti L, Allegra L. No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens. Atherosclerosis. 1996; 126:339-340.
9. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997;96:2144-2148.
10. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle-aged men. Heart. 1996;75:568-572.
11. Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ. 1997;314:1317-1318.
12. Aromaa A, Knekt P, Reunanen A, Rautelin HI, Kosunen TU. Helicobacter infection and the risk of myocardial infarction. Gut. 1996;39(suppl 2):A91. Abstract.
13. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ. 1997;315:1199-1201.
14. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129: 687-702.
15. Jackson R, Chambless LE, Yang K, Byrne T, Watson R, Folsom A, Shahar E, Kalsbeek W. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity. J Clin Epidemiol. 1996;49:1441-1446.
16. Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936-942.
17. Bond MG, Barnes R, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B. High resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimaging. 1991;1:68-73.
18. Riley WA, Barnes R, Bond MG, Evans GW, Chambless L, Heiss G. High resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimaging. 1991;1:168-172.
19. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-246.
20. Siedel J, Hegele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of total serum cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080
21. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-174.
22. 3+ precipitation. Clin Chem. 1982;28:1574. Abstract
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
24. White AD, Folsom AR, Chambless LE, Sharrett AR, Yang K, Conwill D, Higgins M, Williams OD, Tyroler HA. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996;49:223-233.
25. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographs Findings: Standards and Procedures for Measurement and Classification. Littleton, Mass: John Wright; 1982
26. Evans DJ Jr, Evans DG, Graham DY, Klein PD. A sensitive and specific serologic test for detection of Campylobacter pylori infection Gastroenterology. 1989;96:1004-1008.
27. Graham DY, Evans DJ Jr, Peacock J, Baker JT, Schrier WH. Comparison of rapid serologic tests (FlexSure HP and QuickVue) with conventional ELISA for detection of Helicobacter pylori infection. Am J Gastroenterol. 1996;91:942-948.
28. Marchildon PA, Ciota LM, Zamaniyan FZ, Peacock JS, Graham DY. Evaluation of three commercial enzyme immunoassays compared to the C-13 urea breath test for detection of Helicobacter pylori infection. J Clin Microbiol. 1996;34:1147-1152.
29. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 1983;2:644-647.
30. Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, Barnes R, Melnick JL. Cytomegalovirus/herpes virus and carotid atherosclerosis: the ARIC study. J Med Virol. 1994;42:33-37
31. Grayston JT, Kuo C, Wang S, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med. 1986;315:161-168.
32. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, Szklo M, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med. 1993;95:499-504
33. Smolin LA, Schneider JA. Measurement of total plasma cysteamine using high-performance liquid chromatography with electrochemical detection Anal Biochem. 1988;168:374-379.
34. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989; 79:1180-1188.
35. Malinow MR, Sexton G, Averbuch M, Grossman M, Wilson D, Upson G. Homocyst(e)inemia in daily practice: levels in coronary artery disease Coron Artery Dis. 1990;1:215-220.
36. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey-Methods. 2nd ed. Basel, Switzerland: World Health Organization; 1982. World Health Organization monograph series 56.
37. Garber CE, Carleton RA, Heller GV. Comparison of "Rose Questionnaire Angina" to exercise thallium scintigraphy: different findings in males and females. J Clin Epidemiol. 1992;45:715-720.
38. Barlow WE. Robust variance estimation for the case-cohort design Biometrics. 1994;50:1064-1072.
39. Thomas D, Stram D, Dwyer J. Exposure measurement error: influence on exposure-disease: relationships and methods of correction. Annu Rev Public Health. 1993;14:69-93.
40. Mendell MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Northfield TC. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet. 1992;339:986-987
41. Whitaker CJ, Dubiel AJ, Galpin OP. Social and geographical risk factors in Helicobacter pylori infection. Epidemiol Infect 1993;111:63-70
42. Murray LJ, Bamford KB, O'Reilly DPJ, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995; 74:497-501.
43. Parente F, Maconi G, Imbesi V, Sangaletti O, Poggio M, Rossi E, Duca P, Porro GB. Helicobacter pylori infection and coagulation in healthy people. BMJ. 1997;314:1318-1319.
44. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 1991;91:191-205
45. Oldenburg B, Diepersloot RJA, Hoekstra JBL. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci. 1996;41: 458-461.
46. Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. Microbiologica. 1996:19: 149-154.
47. Kojecky V, Roubalik J, Bartonikova N. Helicobacter pylori in patients with diabetes mellitus. Vnitr Lek. 1993;39:581-584